Sutro Biopharma, Inc.: Form 8-K, filed Dec 3, 2025
Filed with the SEC on Dec 3, 2025 and accepted by EDGAR at Dec 3, 2025, 16:30 ET.
Items reported
- Item 3.03 Change to security holders’ rights
- Item 5.03 Amendment to articles or bylaws
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-25-306786. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.